Pre-colostrum and colostrum from goats cause a marked inhibition of the binding of '25I-labelled epidermal growth factor (1251-EGF) to Swiss 3T3 cells. The ability of these secretions to inhibit 1251-EGF binding is closely correlated with the ability to stimulate DNA synthesis in quiescent 3T3 cell cultures, suggesting that goat mammary secretions may contain an EGF-related mitogen. However, the material in colostrum which inhibits '251-EGF binding to Swiss 3T3 cells is a basic protein with Mr> 20000 and is thus quite different from mouse and human EGF. Furthermore, the colostral-mediated inhibition of 1251I-EGF binding, although rapid and apparently competitive, differs from the inhibition of binding induced by native, unlabelled EGF. Thus, the inhibitory effect of colostrum is markedly decreased when the assay temperature is shifted from 370C to 40C whereas unlabelled EGF is an effective competitive inhibitor at both 370C and 40C. Incubation of cells with EGF causes a reduction in cell surface EGF receptors whereas exposure to colostrum does not induce down-regulation of the EGF receptor. Our results suggest that the colostral factor does not bind directly to EGF receptors but inhibits 125I-EGF binding by an indirect mechanism which involves a temperature-sensitive step.
EGF was first isolated from mouse submaxillary gland (Cohen, 1962) and a closely related polypeptide was subsequently purified from human urine (Cohen & Carpenter, 1975; Gregory, 1975) . Both mouse and human EGF are potent stimulators of DNA synthesis and cell proliferation in a wide variety of cell types in culture (Gospodarowicz et al., 1978; Carpenter, 1981) .
Colostrum and pre-colostrum from goats, sheep and cows contain material which inhibits the binding of 1251-EGF to its cellular receptors on mouse 3T3
fibroblasts . The ability of these secretions to inhibit 125I-EGF binding was closely correlated with their ability to stimulate DNA synthesis and proliferation in these cells . EGF is known to be present in mouse and human milk (Hirata & Orth, 1979a,b) and our results suggest that an EGF-like factor may also be present in the mammary secretions of various ungulates. We have therefore investigated the characteristics of the inhibition of 125I-EGF binding by colostrum and the biochemical properties of the inhibitory material in more detail. The results indicate that colostrum contains a Abbreviations used: EGF, epidermal growth factor; 1251-EGF, '25I-labelled EGF; IgG, immunoglobulin G.
Vol. 212 polypeptide growth factor which reduces the affinity of the EGF receptor for EGF. However, the factor differs biochemically from mouse and human EGF and the mechanism by which the factor inhibits EGF binding to its receptor is apparently indirect.
Materials and methods Materials
Culture medium, antibiotics, trypsin and newborn calf serum were from Flow Laboratories. Na251I and [3Hlthymidine were from Amersham International. EGF was prepared from male mouse submaxillary glands by the method of Savage & Cohen (1972) . The lactoperoxidase procedure (Thorell & Johansson, 1971 ) was used to prepare 125I-EGF. The labelled protein was separated from unreacted Na251 by passage of the iodination mixture through a Sephadex G-25 column equilibrated and eluted with a buffer containing 0.01M-phosphate, pH7.4, and 0.15M-NaCl. The labelled EGF was stored frozen in the presence of 0.1% bovine serum albumin. The specific activity of the 125I-EGF, at preparation, was 85000-135000c.p.m./ng. Antiserum to EGF was raised in rabbits as described (Brown & Holley, 1979) . The IgG fraction from the antiserum was prepared by the method of Fahey (1967) and linked to CnBractivated Sepharose (Pharmacia) following the manufacturer's instructions.
Cell cultures
Stock cultures of Swiss mouse 3T3 cells were maintained on 9 cm plastic culture dishes (Nunc) and passaged every three days in DME medium containing 10% (v/v) newborn calf serum, 100 units of penicillin/ml and lOO,ug of streptomycin/ml.
Dishes were incubated at 370C in a humidified atmosphere of C02/air (1:9). For experimental use cells were seeded into 3 cm plastic dishes (Nunc) or 24-well cluster trays (Linbro) and grown for at least 6 days. These cultures were 'quiescent' as judged by a low level of [3Hlthymidine incorporation. After a continuous 30h exposure to 13Hithymidine, less than 1% labelling of cell nuclei could be detected by autoradiography (Brown & Holley, 1979) .
Cell counting
Cells were rinsed with 1-2 ml of Ca2+-and Mg2+-free phosphate-buffered saline which contained 0.43mM-EDTA and 0.05% trypsin. Samples (2 ml) of this solution were then added per 3 cm dish. After 5min incubation at 37°C the cultures could readily be dispersed into a suspension of single cells by gentle pipetting. An aliquot of this suspension was diluted into Isoton and cells were counted on a Coulter Counter (model ZBI). Collection andpreparation ofmammary secretions All samples of pre-colostrum (pre-partum secretions), colostrum (0-24 h post-partum), and milk (later than 24 h post-partum) were collected by hand milking. The pre-partum samples were kept to a minimal volume in order to avoid initiating lactogenesis (Linzell & Peaker, 1974) . The samples were centrifuged for 30min at 30000g and the aqueous phase withdrawn from below the floating lipid. The casein from some samples was precipitated by lowering the pH to 4.3 by the dropwise addition of 1 M-acetic acid.
I21-EGF binding assay
Confluent cultures of cells were washed with 1-2 ml of binding medium which consisted of DME containing 0.1% crystalline bovine serum albumin, -0.1,pM-KI and 50 mM-Bes[NN-bis(2-hydroxyethyl)-2-aminoethanesulphonic acid] adjusted to pH 7.0.
The cells were incubated at 4 0 C or 37°C with I ml (3cm dishes) or 0.5 ml (multiwells) of binding medium containing 125I-EGF at the required concentration. The test dishes also received the volume of pre-colostrum, colostrum or milk indicated in the Figure legends. After incubation, unbound radioactivity was removed by washing the cells four times with cold (40C) phosphate-buffered saline (pH 7.4) containing 0.1% albumin and 0.1 M-KI. The washed cells were extracted (60min at 370C) into 1 ml of 0.5 M-NaOH, and cell-associated radioactivity was determined in a gamma counter. Non-specific '25I-EGF binding measured as cellassociated radioactivity in the presence of unlabelled EGF (2,ug/ml) was less than 5% of the total.
Cell numbers were obtained from replicate dishes of cells treated with trypsin/EDTA as described above. (20,ul) was added per dish to give a final concentration of 1 Ci/ml (1 x 10-6M). After incubation for 40h at 370C, the medium was removed from the dishes and the cells were washed twice with cold phosphate-buffered saline (pH7.4). The cells were extracted for 30min with 1-2ml of cold 5% (w/v) trichloroacetic acid, rinsed with ethanol, and air dried. The cells were dissolved in 1 ml of 0.1 M-NaOH and 0.5 ml of this solution was mixed with lOml of acidified scintillation fluid for counting of 3H.
Results
A mitogen in goat mammary secretions inhibits EGF binding to 3T3 cells Goat pre-colostrum or colostrum (4%, v/v) caused an 80% inhibition of the binding of 1251-EGF to 3T3 cells (Fig. 1) . In contrast, 4% (v/v) milk obtained from the same animal 1 day post-partum caused only 8% inhibition of binding (Fig. 1) . The ability of mammary secretions to stimulate DNA synthesis in quiescent 3T3 cells cultures followed a similar pattern, i.e. high activity levels in pre-colostrum and colostrum, low activity levels in milk (Fig. 1) . When lactogenesis was initiated prematurely by prepartum milking, the levels of cell growth-promoting activity and the levels of 125I-EGF-inhibiting activity in mammary secretions showed a parallel decline before parturition (Fig. 1) . The results presented in Fig. 1 were obtained using defatted samples (see the Materials and methods section). Tests on representative defatted and decaseinated samples produced quantitatively similar results (not shown) indicating that the growth-promoting and the 1251-EGF-inhibitory activity are present in the aqueous, non-casein (i.e. whey) fraction of the secretions. Treatment with proteolytic enzymes (trypsin plus chymotrypsin, both at 0.5 mg/ml final concentration, for 4h at 370C) or reducing agents led to a complete loss of both growth-promoting and 1251-EGF-inhibiting activities. In contrast, heating whey to 100°C for 2min caused only a small (approx. cells by goat mammary secretions Samples of secretions were obtained from goats 668 (squares) and 390 (circles) on the days indicated relative to parturition (day 0). The pre-partum samples from 668 were kept to a minimal volume (2-3 ml) to avoid initiating lactogenesis. Starting 8 days pre-partum, goat 390 was handmilked twice daily to remove all secretion from the gland cistern. This procedure led to a rapid initiation of lactogenesis prior to parturition. 125I-EGF binding assay: quiescent cultures of 3T3 cells were incubated with 0.5 ml of binding medium containing '251-EGF (1 ng/ml) (41 000c.p.m./ng) and 40,u1 of mammary secretions/ml. After 90min at 370C the cells were washed and cell-associated radioactivity was determined as described in the Materials and methods section. Each point represents the mean value (n = 2 or 3)
for the percentage inhibition of 1251-EGF binding relative to the binding to untreated, control cells. DNA synthesis assay: mammary secretions (25,ul/ml of medium) and [3H]thymidine were added directly to the depleted growth medium of quiescent cultures of 3T3 cells grown on 3 cm dishes. After a 40h incubation at 370C, the incorporation of radioactivity into acid-precipitable material was measured as described in the Materials and methods section. Each Colostrum was dialysed (Spectrapor 3) versus several changes of 0.02 M-ammonium formate (pH 5.6), centrifuged, lyophilized and redissolved (one-fifth of original volume) in phosphate-buffered saline, pH 7.4. Concentrated colostrum (0.2 ml) was applied to a column (1 5cm x 0.7 cm) of Bio-Gel P-10 equilibrated and eluted with phosphatebuffered saline. Fractions (0.5 ml) were collected and assayed for their ability to stimulate DNA synthesis (0) and to inhibit '25I-EGF binding (0) in Vol. 212 15%) loss in both activities and heating to 600C for 30min was without effect on either activity (results not shown). A sample of colostrum was chromatographed on a Bio-Gel P-10 column. Fractions from the column were tested for their ability to stimulate DNA synthesis in quiescent 3T3 cells and for their ability to inhibit 1251I-EGF binding to these cells. A peak of 125I-EGF-inhibiting activity was found to be coeluted with the cell-growth-promoting activity in the column void volume (Fig. 2) . quiescent Swiss 3T3 cells. '23I-EGF binding was measured after a 90min incubation at 370C with 0.5 ml of binding medium containing 125I-EGF (1 ng/ml) (37000c.p.m./ng) and 100l1 of the column fractions/ml. Each point represents the mean value (n = 3) for 125I-EGF binding expressed as a percentage of the control 125I-EGF binding. The stimulation of 3T3 cell DNA synthesis by column fractions (lOO,l/ml of growth medium) was measured as described in the Materials and methods section. Each point represents the mean value of duplicate determinations of [3Hlthymidine incorporation. In this experiment the addition of fresh calf serum (10%, v/v) to the medium produced an incorporation of 4.03 x 104 c.p.m./well. 0 Table 1 . Ion exchange and immunoaffinity chromatographic behaviour of 125I-EGF-inhibiting activity in goat colostrum Decaseinated colostrum was dialysed against 0.02M-ammonium formate (pH 5.6) and 800,1 was applied to a column (3cm x 1.5 cm) of DEAE-cellulose (Whatman DE52) equilibrated with the same buffer. The unretained protein was washed through the column with 0.02 M-ammonium formate (pH 5.6) and the retained protein was eluted with 0.2M-ammonium formate (pH 5.6). Decaseinated colostrum (800,u1) was applied to a column (10 cm x 0.7 cm) of anti-EGF IgG-Sepharose. The unretained protein was washed through the column with phosphatebuffered saline, pH 7.4 and the retained protein was subsequently eluted with 1 M-acetic acid. Decaseinated colostrum was dialysed against 0.02M-Hepes [4 -(2 -hydroxyethyl) -1 -piperazine -ethanesulphonic acidi (pH 7.0) and 800,1 was applied to a column (3 cm x 1.5 cm) of CM-cellulose (Whatman CM52) equilibrated with the same buffer. The unretained protein was washed through the column with 0.02 MHepes (pH 7.0) and the retained proteins were eluted with 0.2 M-Hepes containing 1 M-NaCl (pH 7.0). Retained and unretained eluates from the columns were dialysed against 0.02 M-ammonium formate, lyophilized, redissolved in 800,1 of phosphate- 
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These results indicate that pre-colostrum and colostrum contain high concentrations of a heatstable mitogenic polypeptide which inhibits 1251-EGF binding to cultured 3T3 cells. However, the active material is eluted from a Bio-Gel PIO column well ahead of the mouse EGF elution position (Fig. 2) . In addition, the colostral 125I-EGF-inhibiting activity does not react with antibodies raised against mouse EGF (Table 1) and is not adsorbed to anionexchange cellulose under conditions (Savage & Cohen, 1972) where more than 90% of native mouse EGF is bound (Table 1 ). In contrast, essentially all the activity was retained by a cation-exchange column at pH 7 and could be desorbed from this column using high salt concentrations ( Fig. 3 . In control cultures maximal binding was reached after a 60 min incubation at 370C. Continued incubation with 125I-EGF led to a decrease in cell-associated radioactivity due to the internalization of the 125I-EGFreceptor complex and the subsequent degradation of intracellular 1251-EGF (Carpenter & Cohen, 1976; Brown et al., 1979b) . Colostrum caused a marked reduction in 3T3 cell-associated 125I-EGF (Fig. 3) . This reduction was evident as early as 4 min after the simultaneous addition of colostrum and 125I-EGF to the cells. This result indicates that colostrum reduces total cell-associated radioactivity by inhibiting the initial binding of 125I-EGF to the cells rather than by affecting a subsequent step in the cellular interaction with 125I-EGF. This conclusion is supported by the finding that, at peak control binding (60 min), colostrum produces an 82% inhibition in cell- (Fig. 5) . Thus the mechanisms of colostrum-and EGF-mediated inhibition of 125I-EGF binding must differ since native EGF is an equally effective inhibitor of 125I-EGF binding at 370C and 40C (Fig. 5) . The inhibitory factor in colostrum appears to act by an Vol. 212 Of indirect mechanism which involves a temperaturesensitive step.
Colostrum does not down-regulate EGF receptors. Incubation of cultured cells with EGF leads to a decreased capacity of the cells to rebind EGF. Biochemical and morphological studies have demonstrated that this down-regulation of binding is due to the endocytic internalization of the occupied EGF receptors (reviewed by Haigler & Cohen, 1979; Adamson & Rees, 1981) . The following experiment was undertaken to determine whether exposure of 3T3 cells to colostrum, at a concentration which maximally inhibits 125I-EGF binding, also down regulates EGF receptors. 3T3 cells were pre-incubated with 5% (v/v) colostrum for periods up to 22 h, (Fig. 6) . In contrE 3T3 cells with 125I-EGF led to reduction in the number of cellu (Fig. 6) . Thus, although colostrur inhibitor of 1251-EGF binding inhibitor, in contrast with EGF, is internalization and down-regulat tors.
Discussion
Our results demonstrate that and colostrum contain a growth i which also inhibits 125I-EGF bin
The factor appears to be a ba Mr> 20000 and is thus quite different from human and mouse EGF. Furthermore, the characteristics of the inhibition of 125I-EGF binding by colostrum differ from that produced by native EGF. Colostrum-induced inhibition is temperature-dependent whereas EGF-mediated inhibition is temperature-\ independent. Colostrum, at concentrations which maximally inhibit i25I-EGF binding, fails to induce down-regulation of 3T3 cell EGF receptors even after a 22h incubation with the cells. Indeed, the initial effect of pretreatment with colostrum is to increase 125I-EGF binding (Fig. 6 ). The addition of colostrum to the growth medium of quiescent cells causes an early decrease in protein degradation (Ballard et al., 1982) (Rozengurt et al., 1981) , and fibroblasts unable to promote derived growth factor isolated from the conditioned :ion of EGF recepmedium of SV40 BHK cells (Rozengurt et al., 1982) . The nature of the processes involved in this indirect inhibition is not known. The inhibitory effect does not require an intact cytoskeleton, protein synthesis, energy metabolism or the maintenance goat pre-colostrum -f ion gradients across the plasma membrane factor for 3T3 cells (Rozengurt et al., 1982) . The effect is, however, iding to these cells. markedly reduced at low temperature and it may lsic polypeptide of be that a temperature-dependent lateral movement of receptor proteins within the plasma membrane is required to establish the inhibition. The results presented in this work suggest that inhibition of 251I-EGF binding by the colostral factor is mediated by a similar mechanism. The indirect nature of the inhibition of EGF binding by the colostral factor, together with the observation that the factor has biochemical characteristics quite different from those of mouse and human EGF, indicate that this factor is not an EGF-related polypeptide. The cell growth-promoting properties of human colostrum have not yet been investigated but human milk contains cell-growthstimulating activity (Klagsbrun, 1978) which appears to be due, primarily, to its EGF content (Carpenter, 1980) . In contrast, although goat, cow and sheep pre-colostrum and colostrum contain high levels of cell growth-promoting activity, milk from these species contains little or no activity (Klagsbrun & Neumann, 1979; . Furthermore, we have now found that the major growth-promoting activity in goat colostrum is due to a factor apparently unrelated to EGF. Thus, our results indicate that both qualitative and quantitative species differences exist in the growth factor content of mammary secretions.
The origin of colostral growth factor(s) is unknown. The high levels in pre-colostrum and colostrum, together with the rapid fall in levels at lactogenesis, are characteristic of the concentration of several blood-derived proteins in mammary secretions (McClelland et al., 1978; Healy et al., 1980) . Although synthesis of the factor by the mammary gland cannot be excluded, it is probable that the colostral factor is transferred from the blood across the mammary epithelium. The pathway for this transfer could be paracellular, i.e., between the secretory cells. Alternatively a transcellular mechanism may operate whereby the factor is bound to receptors on the baso-lateral membrane, internalized by the epithelial cells and subsequently secreted across the apical membrane into the alveolar lumen. It is now well established that a wide variety of cell types bind and internalize various polypeptide hormones and growth factors, including EGF (Haigler & Cohen, 1979; Adamson & Rees, 1981) . This internalization leads to the lysosomal degradation of the factor. However, it is conceivable that in secretory epithelia a modification of this pathway could permit the passage of an undegraded growth factor through the cell. We have infused 125I-EGF close-arterially into the mammary gland of goats and have found that intact, immunoreactive '25I-EGF appears in the mammary secretions after a lag of 30-35 min . Further experiments are in progress to investigate the mechanism of this transfer.
The physiological role of cell growth-promoting agents in mammary secretions remains to be determined. Polypeptide growth factors, including EGF, have been shown to influence the growth and development of mammary tissue in vitro (Topper & Freeman, 1980; Salomon et al., 1981) , and the factor may be involved in the growth and development of the mammary gland prior to parturition and lactogenesis (Knight & Peaker, 1982) . Alternatively, the factor may be involved in neonatal growth and development. Widdowson et al. (1976) found that the small intestine of piglets fed sow colostrum was markedly increased in weight and length compared with that of piglets fed water during the first 24 h postpartum. Heird & Hansen (1977) found that small intestinal mucosal mass, DNA and protein content and enzyme activity increased in response to ingestion of colostrum when compared with an intake of an isocaloric simulated milk. These observations raise the possibility that growth factors in mammary secretions may be involved in controlling the early growth and maturation of the epithelial cells of the neonate's intestine.
